Literature DB >> 14302358

THE INITIAL INACTIVATION OF PHENELZINE BY A MONOAMINE OXIDASE-LIKE SYSTEM IN VITRO AND IN VIVO.

A HORITA.   

Abstract

Entities:  

Keywords:  EXPERIMENTAL LAB STUDY; LIVER ENZYMOLOGY; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PHARMACOLOGY; PHENELZINE; RATS

Mesh：

Substances：

Year:  1965        PMID： 14302358      PMCID： PMC1704065          DOI： 10.1111/j.1476-5381.1965.tb02100.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  10 in total

1.  VOLATILE AMINE OXIDASE INHIBITOR FROM HYDRAZINE DERIVATIVES.

Authors:  M KORY; E MINGIOLI
Journal:  Biochem Pharmacol       Date:  1964-04       Impact factor: 5.858

2.  THE INFLUENCE OF DRUG-TISSUE INTERACTIONS ON THE INHIBITION OF MONOAMINE OXIDASE BY PHENIPRAZINE AND IPRONIAZID.

Authors:  A HORITA
Journal:  J Pharmacol Exp Ther       Date:  1963-11       Impact factor: 4.030

3.  STUDIES ON MONOAMINE OXIDASE: THE MECHANISM OF INHIBITION OF MONOAMINE OXIDASE BY IPRONIAZID.

Authors:  T E SMITH; H WEISSBACH; S UDENFRIEND
Journal:  Biochemistry       Date:  1963 Jul-Aug       Impact factor: 3.162

4.  Amine oxidases. XI. Inhibition of monoamine oxidase by 1-isonicotinyl-2-isopropylhydrazine.

Authors:  E A ZELLER; J BARSKY; E R BERMAN
Journal:  J Biol Chem       Date:  1955-05       Impact factor: 5.157

5.  The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.

Authors:  A HORITA
Journal:  Toxicol Appl Pharmacol       Date:  1961-07       Impact factor: 4.219

6.  Biochemical and pharmacological studies of beta-phenylethylhydrazine and selected related compounds.

Authors:  M CHESSIN; B DUBNICK; G LEESON; C C SCOTT
Journal:  Ann N Y Acad Sci       Date:  1959-09       Impact factor: 5.691

7.  The interaction between reversible and irreversible monoamine oxidase inhibitors.

Authors:  A HORITA; W R McGRATH
Journal:  Biochem Pharmacol       Date:  1960-06       Impact factor: 5.858

8.  Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.

Authors:  A HORITA; W R McGRATH
Journal:  Proc Soc Exp Biol Med       Date:  1960-04

9.  Assay of serotonin and related metabolites, enzymes, and drugs.

Authors:  S UDENFRIEND; H WEISSBACH; B B BRODIE
Journal:  Methods Biochem Anal       Date:  1958

10.  Amine oxidase and amine metabolism.

Authors:  H BLASCHKO
Journal:  Pharmacol Rev       Date:  1952-12       Impact factor: 25.468
  10 in total
  2 in total

1.  Auto-potentiation and potentiation by inhibition of monoamine oxidase of the sympathomimetic action of phenelzine and pheniprazine.

Authors:  V Clineschmidt; A Horita
Journal:  Br J Pharmacol Chemother       Date:  1967-05

Review 2.  Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.

Authors:  Dmitriy Matveychuk; Erin M MacKenzie; David Kumpula; Mee-Sook Song; Andrew Holt; Satyabrata Kar; Kathryn G Todd; Paul L Wood; Glen B Baker
Journal:  Cell Mol Neurobiol       Date:  2021-04-10       Impact factor: 5.046
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.